Severe side effects in patients with B-cell chronic lymphocytic leukemia (CLL) and lymphocytosis treated with the monoclonal anti-CD20 antibody rituximab.

被引：0
|
作者：
Winkler, U [1 ]
Jensen, M [1 ]
Manzke, O [1 ]
Tesch, H [1 ]
Bohlen, H [1 ]
Diehl, V [1 ]
Engert, A [1 ]
机构：
[1] Univ Cologne, Dept Internal Med 1, Cologne, Germany
来源：
BLOOD | 1998年 / 92卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4228
引用
收藏
页码：285B / 285B
页数：1
相关论文
共 50 条
  • [41] The latest developments with anti-CD20 monoclonal antibodies in chronic lymphocytic leukemia
    Evers, Mitchell
    Jak, Margot
    Leusen, J. H. W.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2018, 18 (09) : 973 - 982
  • [42] Monoclonal antibody therapy for B-Cell lymphoma: Clinical trials of an anti-CD20 monoclonal antibody for B-cell lymphoma in Japan
    Tobinai, K
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2002, 76 (05) : 411 - 419
  • [43] Monoclonal Antibody Therapy for B-Cell Lymphoma: Clinical Trials of an Anti-CD20 Monoclonal Antibody for B-Cell Lymphoma in Japan
    Kensei Tobinai
    International Journal of Hematology, 2002, 76 : 411 - 419
  • [44] Loss of CD20 expression following treatment with anti-CD20 monoclonal antibody in chronic lymphocytic leukemia.
    Savage, KJ
    Weng, AP
    Kutok, JL
    Pinkus, G
    Gribben, JG
    BLOOD, 2002, 100 (11) : 364B - 364B
  • [45] Ofatumumab, a Novel Anti-CD20 Monoclonal Antibody for the Treatment of B-Cell Malignancies
    Cheson, Bruce D.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (21) : 3525 - 3530
  • [46] Anti-CD20 monoclonal antibody as a new treatment modality for B-cell lymphoma
    Hotta, T
    ACTA HISTOCHEMICA ET CYTOCHEMICA, 2002, 35 (04) : 275 - 279
  • [47] Telomere Dynamics in Monoclonal B-Cell Lymphocytosis and Binet a Chronic Lymphocytic Leukemia
    Furtado, Felipe M.
    Matos, Daniel M.
    Scatena, Natalia Ferreira
    Santana, Barbara
    Sheucher, Priscila Santos
    Rego, Eduardo Magalhaes
    Calado, Rodrigo T.
    Falcao, Roberto P.
    BLOOD, 2015, 126 (23)
  • [48] Modulation of CD20 expression in B-cell lymphomas treated with rituximab.
    Seliem, RM
    Freeman, JK
    Hasserjian, RP
    BLOOD, 2002, 100 (11) : 311B - 311B
  • [49] B-cell monoclonal lymphocytosis and B-cell abnormalities in the setting of familial B-cell chronic lymphocytic leukemia
    Marti, GE
    Carter, P
    Abbasi, F
    Washington, GC
    Jain, N
    Zenger, VE
    Ishibe, N
    Goldin, L
    Fontaine, L
    Weissman, N
    Sgambati, M
    Fauget, G
    Bertin, P
    Vogt, RF
    Slade, B
    Noguchi, PD
    Stetler-Stevenson, MA
    Caporaso, N
    CYTOMETRY PART B-CLINICAL CYTOMETRY, 2003, 52B (01) : 1 - 12
  • [50] COVID-19 in patients with chronic lymphocytic leukemia treated with venetoclax: what is the role of anti-CD20 antibody?
    Autore, Francesco
    Visentin, Andrea
    Deodato, Marina
    Vitale, Candida
    Galli, Eugenio
    Fresa, Alberto
    Fazzi, Rita
    Sanna, Alessandro
    Olivieri, Jacopo
    Scortechini, Ilaria
    Principe, Maria Ilaria Del
    Sportoletti, Paolo
    Innocenti, Idanna
    Coscia, Marta
    Tedeschi, Alessandra
    Trentin, Livio
    Candoni, Anna
    Busca, Alessandro
    Pagano, Livio
    Laurenti, Luca
    BLOOD ADVANCES, 2025, 9 (01) : 162 - 165
12345